4/A//SEC Filing
TOLAN MARY A 4/A
Accession 0001232914-26-000002
CIK 0001832511other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:13 PM ET
Size
5.7 KB
Accession
0001232914-26-000002
Research Summary
AI-generated summary of this filing
P3 Health Partners Director Mary Tolan Receives 2,000 RSUs
What Happened
- Mary A. Tolan, a director of P3 Health Partners, was granted 2,000 restricted stock units (RSUs) on August 6, 2025. The grant was reported as an award (code A) at $0.00 per share (i.e., no cash paid).
- Each RSU represents a right to receive one share of the company's Class A common stock. The RSUs vest upon the earlier of the company's 2026 annual stockholder meeting and the one‑year anniversary of the grant date.
Key Details
- Transaction date: 2025-08-06; Grant type: RSUs (Code A); Amount: 2,000 RSUs; Reported price: $0.00.
- Total cash paid: $0 (award/grant, not a purchase).
- Footnote: The RSUs vest on the earlier of the 2026 annual meeting or one year after grant.
- Amended filing: This Form 4 is an amendment to correct the number of securities beneficially owned after a 1-for-50 reverse stock split effective April 11, 2025. The amendment only corrects post‑split ownership reporting.
- Shares owned after the transaction: not specified in the excerpt provided; the amended filing corrects the beneficial‑ownership column following the reverse split.
Context
- This was an equity award, not a market purchase or sale; grants are common for directors and do not, by themselves, indicate buying or selling sentiment.
- The RSUs convert to shares upon vesting (subject to the vesting schedule noted). No immediate exercise or sale was reported.
Insider Transaction Report
Form 4/AAmended
TOLAN MARY A
Director
Transactions
- Award
Class A Common Stock
[F1][F2]2025-08-06+2,000→ 6,331 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date.
- [F2]This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split.
Signature
/s/Todd Smith, Chief Legal Officer, as attorney-in-fact|2026-01-23
Documents
Issuer
P3 Health Partners Inc.
CIK 0001832511
Entity typeother
Related Parties
1- filerCIK 0001232914
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:13 PM ET
- Size
- 5.7 KB